Jelizaveta Geimanen

Title: Jelizaveta Geimanen: Innovator in Viral Expression Technologies

Introduction

Jelizaveta Geimanen is a notable inventor based in Tartu, Estonia. She has made significant contributions to the field of biotechnology, particularly in the development of viral expression plasmids. With a total of 2 patents, her work focuses on the production of proteins, antibodies, enzymes, and virus-like particles.

Latest Patents

Geimanen's latest patents include innovative technologies that enhance the stability and efficiency of plasmid replication. One of her patents details the use of EBV FR-element, which comprises EBNA1 multimeric binding sites, to provide stable maintenance replication functions to mouse polyomavirus core origin plasmids. This technology operates effectively in the presence of BPV-1 E2 protein and PyV large T-antigen. Another patent discusses vectors and cell lines that facilitate extended episomal maintenance replication of hybrid plasmids, demonstrating that MME dependent plasmids can maintain stability with a loss frequency of only 6% per generation.

Career Highlights

Throughout her career, Geimanen has worked with prominent companies in the biotechnology sector, including Icosagen Cell Factory OÜ and Kosagen Cell Factory OÜ. Her expertise in viral expression technologies has positioned her as a key player in the development of advanced biotechnological solutions.

Collaborations

Geimanen has collaborated with esteemed colleagues such as Ene Ustav and Kadri Janikson, contributing to the advancement of research in her field.

Conclusion

Jelizaveta Geimanen's innovative work in viral expression technologies has made a significant impact in biotechnology. Her patents reflect her commitment to advancing scientific knowledge and practical applications in the field.